Investigating the effect of probiotics in septicemia

Phase 3

Recruiting

• Conditions: Condition 1: Neonatal septicemia. Condition 2: Neonatal premature.; Bacterial sepsis of newborn, unspecified; Preterm [premature] newborn [other]; P36.9; P07.3

• Registration Number: IRCT20240213060996N1
• Lead Sponsor: Qazvin University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

All infants who are less than 37 weeks old and weigh less than 2500 grams

Exclusion Criteria

infants under 32 weeks and over 37 weeks
infants who have sepsis due to maternal infection such as PROM and maternal urinary infection
infants who are placed under a ventilator
Parents' unwillingness to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eonatal septicemia. Timepoint: Measurement of CBC, CRP, vital signs, urine culture, duration of hospitalization, duration of full nutrition, blood culture and weight during hospitalization and at the time of discharge. Method of measurement: Blood test, monitoring device, thermometer, urine test, scale.